Therapeutic Lymph Node Dissection in Melanoma: Different Prognosis for Different Macrometastasis Sites?
Main Authors: | Wevers, K. P., Bastiaannet, E., Poos, H. P. A. M., van Ginkel, R. J., Plukker, J. T., Hoekstra, H. J. |
---|---|
Format: | Online |
Language: | English |
Published: |
Springer-Verlag
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3478513/ |
Similar Items
-
Prediction of macrometastasis in axillary lymph nodes of patients with invasive breast cancer and the utility of the SUV lymph node/tumor ratio using FDG-PET/CT
by: Futamura, Manabu, et al.
Published: (2015) -
Therapeutic Surgical Management of Palpable Melanoma Groin Metastases: Superficial or Combined Superficial and Deep Groin Lymph Node Dissection
by: van der Ploeg, A. P. T., et al.
Published: (2011) -
Sentinel node biopsy and radical lymph node dissection for advanced melanoma in the elderly
by: Desiato, V, et al.
Published: (2011) -
Outcome After Therapeutic Lymph Node Dissection in Patients with Unknown Primary Melanoma Site
by: Prens, Sebastiaan P., et al.
Published: (2011) -
Lymphatic Drainage Patterns from Melanomas on the Shoulder or Upper Trunk to Cervical Lymph Nodes and Implications for the Extent of Neck Dissection
by: Veenstra, Hidde J., et al.
Published: (2012)